查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387453

注射用抑菌水市場報告：2030 年趨勢、預測與競爭分析

Bacteriostatic Water for Injection Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

注射用水抑菌趨勢及預測

至2030年，全球抑菌注射水市場預計將達到16億美元，2024年至2030年年複合成長率為6.9%。這個市場的主要促進因素是病原菌的快速生長抑制以及生物製藥和學名藥注射劑行業的快速成長。由於醫院和診所市場的商機，全球抑菌注射水市場的未來前景看好。

注射用抑菌水市場洞察

根據 Lucintel 的預測，由於越來越多的人採用更多注射方式服藥，預計藥物稀釋在預測期內仍將是最大的部分。

在這個市場中，由於醫療保健行業中藥物和注射劑的使用不斷增加，醫院仍然是一個很大的細分市場。

由於給藥，北美仍然是預測期內最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 未來哪個細分市場成長較快？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球注射抑菌水市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球注射抑菌水市場趨勢（2018-2023）與預測（2024-2030）
  • 按配銷通路分類的全球注射抑菌水市場
    • 醫院藥房
    • 線上藥房
    • 其他
  • 全球注射抑菌水市場（按應用）
    • 藥物稀釋
    • 臨床藥理學
    • 抗菌應用
    • 其他
  • 以最終用途分類的全球注射抑菌水市場
    • 醫院
    • 診所
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球注射抑菌水市場（按地區）
  • 北美注射抑菌水市場
  • 歐洲注射用抑菌水市場
  • 亞太注射抑菌水市場
  • 其他地區注射用抑菌水市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 配銷通路的全球注射抑菌水市場成長機會
    • 全球注射抑菌水市場成長機會（按應用）
    • 全球注射抑菌水市場成長機會（依最終用途）
    • 全球注射抑菌水市場成長機會（按地區）
  • 全球抑菌注射用水市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球抑菌注射用水市場產能擴張
    • 全球抑菌注射用水市場合併及收購
    • 認證和許可

第7章 主要企業概況

  • Acella Pharmaceuticals
  • Merck
  • Abbott
  • Procter and Gamble
  • Pfizer
  • Reckitt Benckiser
  • GlaxoSmithKline
簡介目錄

Bacteriostatic Water For Injection Trends and Forecast

The future of the global bacteriostatic water for injection market looks promising with opportunities in the hospital and clinic markets. The global bacteriostatic water for injection market is expected to reach an estimated $1.6 billion by 2030 with a CAGR of 6.9% from 2024 to 2030. The major drivers for this market are swift inhibition of pathogenic bacteria proliferation and rapid growth of the biopharmaceutical and generic injectable medicine industries.

A more than 150-page report is developed to help in your business decisions.

Bacteriostatic Water For Injection by Segment

The study includes a forecast for the global bacteriostatic water for injection by distribution channel, application, end use, and region.

Bacteriostatic Water for Injection Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Online Pharmacies
  • Others

Bacteriostatic Water for Injection Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Medication Dilution
  • Clinical Pharmacology
  • Anti-Bacterial Applications
  • Others

Bacteriostatic Water for Injection Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Others

Bacteriostatic Water for Injection Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bacteriostatic Water For Injection Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bacteriostatic water for injection companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bacteriostatic water for injection companies profiled in this report include-

  • Acella Pharmaceuticals
  • Merck
  • Abbott
  • Procter and Gamble
  • Pfizer
  • Reckitt Benckiser
  • GlaxoSmithKline

Bacteriostatic Water for Injection Market Insights

Lucintel forecasts that medication dilution will remain the largest segment over the forecast period due to increasing number of people adopting more injections to take their medications.

Within this market, hospitals will remain the larger segment due to increasing usage of medications and injections in the healthcare industry.

North America will remain the largest region over the forecast period due to growing number of patients in hospitals, which requires drug administration via intravenous, subcutaneous, and intramuscular methods.

Features of the Global Bacteriostatic Water for Injection Market

Market Size Estimates: Bacteriostatic water for injection market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bacteriostatic water for injection market size by distribution channel, application, end use, and region in terms of value ($B).

Regional Analysis: Bacteriostatic water for injection market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different distribution channels, applications, end uses, and regions for the bacteriostatic water for injection market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bacteriostatic water for injection market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the bacteriostatic water for injection market size?

Answer: The global bacteriostatic water for injection market is expected to reach an estimated $1.6 billion by 2030.

Q2. What is the growth forecast for bacteriostatic water for injection market?

Answer: The global bacteriostatic water for injection market is expected to grow with a CAGR of 6.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bacteriostatic water for injection market?

Answer: The major drivers for this market are swift inhibition of pathogenic bacteria proliferation and rapid growth of the biopharmaceutical and generic injectable medicine industries.

Q4. What are the major segments for bacteriostatic water for injection market?

Answer: The future of the bacteriostatic water for injection market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key bacteriostatic water for injection market companies?

Answer: Some of the key bacteriostatic water for injection companies are as follows:

  • Acella Pharmaceuticals
  • Merck
  • Abbott
  • Procter and Gamble
  • Pfizer
  • Reckitt Benckiser
  • GlaxoSmithKline

Q6. Which bacteriostatic water for injection market segment will be the largest in future?

Answer: Lucintel forecasts that medication dilution will remain the largest segment over the forecast period due to increasing number of people adopting more injections to take their medications.

Q7. In bacteriostatic water for injection market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing number of patients in hospitals, which requires drug administration via intravenous, subcutaneous, and intramuscular methods.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bacteriostatic water for injection market by distribution channel (hospital pharmacies, online pharmacies, and others), application (medication dilution, clinical pharmacology, anti-bacterial applications, and others), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bacteriostatic Water for Injection Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bacteriostatic Water for Injection Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bacteriostatic Water for Injection Market by Distribution Channel
    • 3.3.1: Hospital Pharmacies
    • 3.3.2: Online Pharmacies
    • 3.3.3: Others
  • 3.4: Global Bacteriostatic Water for Injection Market by Application
    • 3.4.1: Medication Dilution
    • 3.4.2: Clinical Pharmacology
    • 3.4.3: Anti-bacterial Applications
    • 3.4.4: Others
  • 3.5: Global Bacteriostatic Water for Injection Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bacteriostatic Water for Injection Market by Region
  • 4.2: North American Bacteriostatic Water for Injection Market
    • 4.2.1: North American Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
    • 4.2.2: North American Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others
  • 4.3: European Bacteriostatic Water for Injection Market
    • 4.3.1: European Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
    • 4.3.2: European Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others
  • 4.4: APAC Bacteriostatic Water for Injection Market
    • 4.4.1: APAC Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
    • 4.4.2: APAC Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others
  • 4.5: ROW Bacteriostatic Water for Injection Market
    • 4.5.1: ROW Bacteriostatic Water for Injection Market by Application: Medication Dilution, Clinical Pharmacology, Anti-bacterial Applications, and Others
    • 4.5.2: ROW Bacteriostatic Water for Injection Market by End Use: Hospitals, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by Distribution Channel
    • 6.1.2: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by Application
    • 6.1.3: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bacteriostatic Water for Injection Market by Region
  • 6.2: Emerging Trends in the Global Bacteriostatic Water for Injection Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bacteriostatic Water for Injection Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bacteriostatic Water for Injection Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Acella Pharmaceuticals
  • 7.2: Merck
  • 7.3: Abbott
  • 7.4: Procter and Gamble
  • 7.5: Pfizer
  • 7.6: Reckitt Benckiser
  • 7.7: GlaxoSmithKline